Koninklijke Philips N.V. (PHG) 10-Year Financial Performance & Capital Metrics

PHG • • Industrial / General

HealthcareMedical DevicesDiagnostic & Imaging EquipmentMedical Imaging Systems

AboutKoninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.Show more

Revenue $18.02B -0.8%
EBITDA $1.92B +67.4%
Net Income -$702M -50.6%
EPS (Diluted) -0.75 -53.1%
Gross Margin 43.13% +5.2%
EBITDA Margin 10.64% +68.7%
Operating Margin 2.94% +563.8%
Net Margin -3.9% -51.9%
ROE -5.82% -58.4%
ROIC 2.29% +590.8%
Debt/Equity 0.62 +2.9%
Interest Coverage 1.57 +517.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading near 52-week high

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-1.7%

5Y1%

3Y1.65%

TTM-1.43%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM150.3%

EPS CAGR

10Y-

5Y-

3Y-

TTM146.18%

ROCE

10Y Avg4.21%

5Y Avg0.85%

3Y Avg-1.54%

Latest2.52%

Peer Comparison

Medical Imaging Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
IRMDIRadimed Corporation	1.3B	102.57	68.38	11.71%	26.31%	21.54%	1.35%	0.00
BRKRBruker Corporation	7.52B	49.46	65.08	13.56%	-0.61%	-0.84%	1.81%	1.24
STESTERIS plc	26.33B	268.26	43.27	6.24%	12.07%	9.8%	2.95%	0.33
FONRFONAR Corporation	114.98M	18.64	15.15	1.43%	7.08%	4.62%	6.48%	0.24
HYPRHyperfine, Inc.	100.18M	1.22	-2.18	16.84%	-378.17%	-149.05%		0.01
PACBPacific Biosciences of California, Inc.	709.48M	2.35	-2.20	-23.19%	-325.8%	-13.95%		1.33
IRIXIRIDEX Corporation	23.21M	1.35	-2.50	-6.17%	-10.04%	-108.67%		2.21
MASS908 Devices Inc.	199.79M	5.52	-2.60	18.72%	-7.17%	-3.03%		0.06

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	24.24B	24.52B	17.78B	18.12B	17.15B	17.31B	17.16B	17.83B	18.17B	18.02B
Revenue Growth %	0.13%	0.01%	-0.27%	0.02%	-0.05%	0.01%	-0.01%	0.04%	0.02%	-0.01%
Cost of Goods Sold+	14.39B	13.9B	9.6B	9.57B	9.2B	9.4B	9.99B	10.63B	10.72B	10.25B
COGS % of Revenue	0.59%	0.57%	0.54%	0.53%	0.54%	0.54%	0.58%	0.6%	0.59%	0.57%
Gross Profit+	9.86B	10.61B	8.18B	8.55B	7.95B	7.91B	7.17B	7.19B	7.45B	7.77B
Gross Margin %	0.41%	0.43%	0.46%	0.47%	0.46%	0.46%	0.42%	0.4%	0.41%	0.43%
Gross Profit Growth %	0.2%	0.08%	-0.23%	0.05%	-0.07%	-0%	-0.09%	0%	0.04%	0.04%
Operating Expenses+	8.86B	8.73B	6.65B	6.83B	6.58B	6.65B	6.62B	8.72B	7.56B	7.24B
OpEx % of Revenue	0.37%	0.36%	0.37%	0.38%	0.38%	0.38%	0.39%	0.49%	0.42%	0.4%
Selling, General & Admin	7.02B	6.73B	4.97B	5.13B	4.56B	4.55B	4.86B	5.29B	5.13B	5.07B
SG&A % of Revenue	0.29%	0.27%	0.28%	0.28%	0.27%	0.26%	0.28%	0.3%	0.28%	0.28%
Research & Development	1.93B	2.02B	1.76B	1.76B	1.79B	1.91B	1.81B	2.09B	1.89B	1.75B
R&D % of Revenue	0.08%	0.08%	0.1%	0.1%	0.1%	0.11%	0.11%	0.12%	0.1%	0.1%
Other Operating Expenses	0	0	21M	9M	232M	183M	-48M	1.34B	541M	429M
Operating Income+	992M	1.88B	1.52B	1.72B	1.37B	1.26B	553M	-1.53B	-115M	529M
Operating Margin %	0.04%	0.08%	0.09%	0.09%	0.08%	0.07%	0.03%	-0.09%	-0.01%	0.03%
Operating Income Growth %	1.04%	0.9%	-0.19%	0.13%	-0.21%	-0.07%	-0.56%	-3.76%	0.92%	5.6%
EBITDA+	2.27B	3.15B	2.54B	2.81B	2.27B	2.33B	1.88B	73M	1.15B	1.92B
EBITDA Margin %	0.09%	0.13%	0.14%	0.15%	0.13%	0.13%	0.11%	0%	0.06%	0.11%
EBITDA Growth %	0.36%	0.39%	-0.19%	0.1%	-0.19%	0.03%	-0.2%	-0.96%	14.7%	0.67%
D&A (Non-Cash Add-back)	1.28B	1.27B	1.02B	1.09B	904M	1.07B	1.32B	1.6B	1.26B	1.39B
EBIT	782M	1.38B	1.62B	1.71B	1.72B	1.69B	673M	-1.49B	-220M	460M
Net Interest Income+	-223M	-421M	-81M	-219M	-96M	-178.98M	-146M	-219M	-260M	-257M
Interest Income	98M	76M	126M	51M	117M	14.82M	18M	25M	46M	79M
Interest Expense	467M	569M	263M	264M	233M	193.8M	164M	244M	306M	337M
Other Income/Expense	-329M	-75M	-140M	-216M	-119M	-53M	-44M	-202M	-412M	-406M
Pretax Income+	623M	1.39B	1.38B	1.5B	1.25B	1.21B	509M	-1.73B	-527M	123M
Pretax Margin %	0.03%	0.06%	0.08%	0.08%	0.07%	0.07%	0.03%	-0.1%	-0.03%	0.01%
Income Tax+	239M	327M	349M	193M	258M	212M	-103M	-113M	-73M	963M
Effective Tax Rate %	1.04%	1.04%	1.2%	0.73%	0.94%	0.98%	6.52%	0.93%	0.88%	-5.71%
Net Income+	645M	1.45B	1.66B	1.09B	1.17B	1.19B	3.32B	-1.61B	-466M	-702M
Net Margin %	0.03%	0.06%	0.09%	0.06%	0.07%	0.07%	0.19%	-0.09%	-0.03%	-0.04%
Net Income Growth %	0.55%	1.24%	0.14%	-0.34%	0.07%	0.02%	1.8%	-1.48%	0.71%	-0.51%
Net Income (Continuing)	160M	831M	1.03B	1.31B	989M	999M	612M	-1.62B	-454M	-840M
Discontinued Operations	479M	660M	843M	0	183M	196M	2.71B	13M	-10M	142M
Minority Interest	118M	907M	24M	29M	28M	31M	36M	34M	33M	37M
EPS (Diluted)+	0.66	1.46	1.64	1.09	1.20	1.23	0.64	-1.68	-0.49	-0.75
EPS Growth %	0.57%	1.21%	0.12%	-0.34%	0.1%	0.03%	-0.48%	-3.63%	0.71%	-0.53%
EPS (Basic)	0.66	1.48	1.67	1.11	1.21	1.25	0.67	-1.68	-0.49	-0.75
Diluted Shares Outstanding	984.45M	989.95M	1.01B	997.48M	972.79M	957.56M	950.28M	952.46M	948.79M	933.37M
Basic Shares Outstanding	976.41M	978.47M	989.96M	983.77M	962.2M	948.26M	907.46M	952.46M	948.79M	933.37M
Dividend Payout Ratio	0.46%	0.23%	0.23%	0.37%	0.43%	0%	0.17%	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	12.69B	14.07B	10.12B	9.57B	9.46B	11.23B	10.35B	10.26B	9.94B	10.02B
Cash & Short-Term Investments	1.78B	2.44B	1.94B	2.12B	1.43B	3.23B	2.31B	1.18B	1.87B	2.4B
Cash Only	1.77B	2.33B	1.94B	1.69B	1.43B	3.23B	2.3B	1.17B	1.87B	2.4B
Short-Term Investments	12M	101M	2M	436M	1M	0	2M	11M	3M	2M
Accounts Receivable	5.1B	5.63B	4.2B	4.18B	5.02B	4.16B	4.29B	4.65B	4.25B	3.67B
Days Sales Outstanding	76.72	83.81	86.3	84.24	106.84	87.64	91.23	95.27	85.4	74.37
Inventory	3.46B	3.39B	2.35B	2.67B	2.77B	2.99B	3.45B	4.05B	3.49B	3.2B
Days Inventory Outstanding	87.85	89.04	89.46	102.01	110.03	116.21	126.08	138.99	118.85	113.9
Other Current Assets	2.49B	2.66B	1.71B	776M	53M	682M	132M	200M	129M	511M
Total Non-Current Assets+	18.28B	18.23B	15.2B	16.45B	17.56B	16.49B	20.61B	20.43B	19.47B	18.95B
Property, Plant & Equipment	2.32B	2.15B	1.59B	1.71B	2.87B	2.68B	2.7B	2.64B	2.48B	2.45B
Fixed Asset Turnover	10.44x	11.38x	11.18x	10.58x	5.98x	6.46x	6.36x	6.76x	7.31x	7.35x
Goodwill	8.52B	8.9B	7.73B	8.5B	8.65B	8.01B	10.64B	10.24B	9.88B	10.38B
Intangible Assets	3.69B	3.55B	3.32B	3.59B	3.47B	3B	3.65B	3.53B	3.19B	2.98B
Long-Term Investments	670M	525M	729M	604M	481M	670M	1.06B	1.2B	1B	889M
Other Non-Current Assets	317M	306M	227M	211M	225M	303M	355M	381M	287M	332M
Total Assets+	30.98B	32.3B	25.32B	26.02B	27.02B	27.71B	30.96B	30.69B	29.41B	28.98B
Asset Turnover	0.78x	0.76x	0.70x	0.70x	0.63x	0.62x	0.55x	0.58x	0.62x	0.62x
Asset Growth %	0.09%	0.04%	-0.22%	0.03%	0.04%	0.03%	0.12%	-0.01%	-0.04%	-0.01%
Total Current Liabilities+	10.07B	10.47B	6.87B	7.94B	6.98B	7.74B	7.45B	7.93B	8.29B	8.14B
Accounts Payable	2.67B	2.85B	2.09B	2.3B	2.09B	2.12B	1.87B	1.97B	1.92B	1.83B
Days Payables Outstanding	67.81	74.76	79.46	87.85	82.89	82.27	68.41	67.56	65.26	65.18
Short-Term Debt	1.67B	1.58B	585M	1.3B	110M	962M	53M	95M	123M	224M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	3.07B	3.09B	1.96B	2.09B	937M	785M	1.39B	1.95B	1.93B	2.19B
Current Ratio	1.26x	1.34x	1.47x	1.21x	1.36x	1.45x	1.39x	1.29x	1.20x	1.23x
Quick Ratio	0.92x	1.02x	1.13x	0.87x	0.96x	1.06x	0.93x	0.78x	0.78x	0.84x
Cash Conversion Cycle	96.76	98.09	96.3	98.39	133.98	121.57	148.89	166.7	138.99	123.1
Total Non-Current Liabilities+	9.13B	8.32B	6.43B	5.96B	7.41B	8.08B	9.04B	9.47B	9.06B	8.79B
Long-Term Debt	3.95B	3.83B	3.85B	3.19B	3.77B	4.76B	4.77B	6.17B	6.09B	6.19B
Capital Lease Obligations	145M	194M	195M	236M	1.11B	948M	963M	852M	864M	854M
Deferred Tax Liabilities	164M	66M	33M	152M	143M	59M	83M	91M	71M	81M
Other Non-Current Liabilities	5.03B	4.3B	2.1B	2.53B	2.05B	1.91B	2.77B	1.85B	1.56B	1.23B
Total Liabilities	19.2B	18.8B	13.29B	13.9B	14.39B	15.81B	16.49B	17.41B	17.34B	16.93B
Total Debt+	5.76B	5.61B	4.72B	4.82B	5.26B	6.93B	6.05B	7.34B	7.29B	7.49B
Net Debt	3.99B	3.27B	2.78B	3.13B	3.83B	3.71B	3.74B	6.17B	5.42B	5.09B
Debt / Equity	0.49x	0.42x	0.39x	0.40x	0.42x	0.58x	0.42x	0.55x	0.60x	0.62x
Debt / EBITDA	2.53x	1.78x	1.86x	1.72x	2.32x	2.97x	3.22x	100.58x	6.36x	3.91x
Net Debt / EBITDA	1.76x	1.04x	1.09x	1.12x	1.69x	1.59x	2.00x	84.52x	4.73x	2.65x
Interest Coverage	2.12x	3.31x	5.77x	6.51x	5.86x	6.52x	3.37x	-6.27x	-0.38x	1.57x
Total Equity+	11.78B	13.51B	12.02B	12.12B	12.63B	11.9B	14.47B	13.28B	12.06B	12.04B
Equity Growth %	0.07%	0.15%	-0.11%	0.01%	0.04%	-0.06%	0.22%	-0.08%	-0.09%	-0%
Book Value per Share	11.97	13.65	11.94	12.15	12.98	12.43	15.23	13.95	12.71	12.90
Total Shareholders' Equity	11.66B	12.6B	12B	12.09B	12.6B	11.87B	14.44B	13.25B	12.03B	12.01B
Common Stock	186M	186M	188M	185M	179M	182M	177M	178M	183M	188M
Retained Earnings	8.04B	8.23B	8.6B	8.27B	8.3B	7.83B	9.34B	6.83B	5.4B	3.65B
Treasury Stock	-363M	-181M	-481M	-399M	-201M	-199M	-476M	-275M	-262M	-411M
Accumulated OCI	1.13B	1.28B	11.81B	11.9B	652M	-340M	748M	1.49B	879M	1.93B
Minority Interest	118M	907M	24M	29M	28M	31M	36M	34M	33M	37M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	1.17B	1.9B	1.87B	1.78B	2.27B	2.64B	1.93B	-181.82M	2.31B	1.7B
Operating CF Margin %	0.05%	0.08%	0.11%	0.1%	0.13%	0.15%	0.11%	-0.01%	0.13%	0.09%
Operating CF Growth %	-0.1%	0.63%	-0.02%	-0.05%	0.28%	0.16%	-0.27%	-1.09%	13.7%	-0.27%
Net Income	414M	1.07B	1.03B	1.31B	1.33B	1.19B	718.64M	-1.7B	-492.99M	-912.95M
Depreciation & Amortization	1.28B	1.27B	1.02B	1.09B	1.09B	1.46B	1.24B	1.26B	1.39B	1.26B
Stock-Based Compensation	82M	95M	122M	102M	0	112M	0	0	0	0
Deferred Taxes	239M	327M	349M	193M	0	284M	0	0	0	0
Other Non-Cash Items	382M	1.25B	1.46B	962M	609.99M	131M	143.02M	1.5B	-98.38M	1.35B
Working Capital Changes	-346M	-512M	-509M	-500M	-755.49M	-536M	-179.66M	-1.24B	1.51B	7.57M
Change in Receivables	-554M	357M	64M	-97M	0	92M	0	-359.43M	322.17M	-1.08M
Change in Inventory	22M	44M	-144M	-394M	-195.87M	-578M	-686.73M	-601.16M	277.85M	248.79M
Change in Payables	464M	-154M	0	0	-413M	0	258.85M	54.65M	387.04M	-630.63M
Cash from Investing+	-1.94B	-1.17B	-3.2B	-1.49B	-702.89M	-1.27B	-317.95M	-1.58B	-553.53M	-633.87M
Capital Expenditures	-957M	-869M	-859M	-843M	-1.13B	-895M	-901.85M	-847.09M	-695.16M	-731.22M
CapEx % of Revenue	0.04%	0.04%	0.05%	0.05%	0.07%	0.05%	0.05%	0.05%	0.04%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	516M	-1.11B	-463M	-549M	-27.98M	20M	4.02B	-12.61M	134.06M	27.04M
Cash from Financing+	508M	-420M	55M	-1.19B	-1.86B	483M	-2.77B	525.49M	-916.79M	-536.52M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-298M	-330M	-384M	-401M	-507.02M	-1M	-569.71M	-433M	-2.16M	-1.08M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	81M	2.98B	1.3B	125M	-2.24M	60M	-2.36M	-6.31M	-3.24M	-2.16M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	210M	1.03B	1.01B	937M	1.69B	2.15B	1.46B	-648.45M	1.94B	1.35B
FCF Margin %	0.01%	0.04%	0.06%	0.05%	0.1%	0.12%	0.08%	-0.04%	0.11%	0.08%
FCF Growth %	-0.54%	3.93%	-0.02%	-0.07%	0.81%	0.27%	-0.32%	-1.44%	3.99%	-0.3%
FCF per Share	0.21	1.05	1.00	0.94	1.74	2.25	1.53	-0.68	2.04	1.45
FCF Conversion (FCF/Net Income)	1.81x	1.31x	1.13x	1.63x	1.95x	2.22x	0.58x	0.11x	-4.96x	-2.42x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	5.67%	11.45%	12.98%	9.03%	9.43%	9.68%	25.17%	-11.59%	-3.68%	-5.82%
Return on Invested Capital (ROIC)	5.14%	8.67%	7.21%	8.58%	6.46%	5.91%	2.45%	-6.09%	-0.47%	2.29%
Gross Margin	40.65%	43.29%	46.01%	47.2%	46.35%	45.7%	41.78%	40.35%	40.99%	43.13%
Net Margin	2.66%	5.91%	9.32%	6.02%	6.81%	6.86%	19.35%	-9.02%	-2.56%	-3.9%
Debt / Equity	0.49x	0.42x	0.39x	0.40x	0.42x	0.58x	0.42x	0.55x	0.60x	0.62x
Interest Coverage	2.12x	3.31x	5.77x	6.51x	5.86x	6.52x	3.37x	-6.27x	-0.38x	1.57x
FCF Conversion	1.81x	1.31x	1.13x	1.63x	1.95x	2.22x	0.58x	0.11x	-4.96x	-2.42x
Revenue Growth	13.34%	1.12%	-27.48%	1.92%	-5.38%	0.97%	-0.91%	3.91%	1.92%	-0.81%

Revenue by Geography

	2017	2018	2019	2020	2021	2022	2024
UNITED STATES	-	-	6.67B	-	-	-	7.23B
UNITED STATES Growth	-	-	-	-	-	-	-
Other countries	5.93B	6.09B	6.34B	6.43B	5.04B	5.08B	5.6B
Other countries Growth	-	2.56%	4.12%	1.48%	-21.64%	0.89%	10.05%
NETHERLANDS	-	-	522M	-	-	-	2.51B
NETHERLANDS Growth	-	-	-	-	-	-	-
CHINA	-	-	2.71B	-	-	-	1.15B
CHINA Growth	-	-	-	-	-	-	-
JAPAN	-	-	1.19B	-	-	-	886M
JAPAN Growth	-	-	-	-	-	-	-
GERMANY	-	-	1.09B	-	-	-	653M
GERMANY Growth	-	-	-	-	-	-	-
United States of America	-	6.05B	-	6.64B	6.42B	7.25B	-
United States of America Growth	-	-	-	-	-3.25%	12.87%	-
China	2.32B	2.38B	-	2.43B	2.33B	2.19B	-
China Growth	-	2.50%	-	-	-3.99%	-6.08%	-
Japan	1.06B	1.04B	-	1.31B	1.07B	1.08B	-
Japan Growth	-	-1.32%	-	-	-18.34%	0.37%	-
Germany	1.01B	1.03B	-	1.11B	839M	821M	-
Germany Growth	-	2.08%	-	-	-24.62%	-2.15%	-
Netherlands	414M	510M	-	555M	570M	540M	-
Netherlands Growth	-	23.19%	-	-	2.70%	-5.26%	-
United Kingdom of Great Britain and Northern Ireland	-	-	-	-	481M	463M	-
United Kingdom of Great Britain and Northern Ireland Growth	-	-	-	-	-	-3.74%	-
France	530M	519M	-	545M	397M	400M	-
France Growth	-	-2.08%	-	-	-27.16%	0.76%	-
Korea (Republic of)	-	498M	-	509M	-	-	-
Korea (Republic of) Growth	-	-	-	-	-	-	-
FRANCE	-	-	505M	-	-	-	-
FRANCE Growth	-	-	-	-	-	-	-
KOREA, REPUBLIC OF	-	-	470M	-	-	-	-
KOREA, REPUBLIC OF Growth	-	-	-	-	-	-	-
United States	6.08B	-	-	-	-	-	-
United States Growth	-	-	-	-	-	-	-
India	425M	-	-	-	-	-	-
India Growth	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Koninklijke Philips N.V. (PHG) reported $17.78B in revenue for fiscal year 2024. This represents a 21% decrease from $22.58B in 2011.

Koninklijke Philips N.V. (PHG) saw revenue decline by 0.8% over the past year.

Yes, Koninklijke Philips N.V. (PHG) is profitable, generating $165.0M in net income for fiscal year 2024 (-3.9% net margin).

Dividend & Returns

Koninklijke Philips N.V. (PHG) does not currently pay a meaningful dividend. The company may be reinvesting profits for growth.

Koninklijke Philips N.V. (PHG) has a return on equity (ROE) of -5.8%. Negative ROE indicates the company is unprofitable.

Koninklijke Philips N.V. (PHG) had negative free cash flow of $552.8M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Koninklijke Philips N.V. (PHG) 10-Year Financial Performance & Capital Metrics

PHG • • Industrial / General

HealthcareMedical DevicesDiagnostic & Imaging EquipmentMedical Imaging Systems

Revenue $18.02B -0.8%
EBITDA $1.92B +67.4%
Net Income -$702M -50.6%
EPS (Diluted) -0.75 -53.1%
Gross Margin 43.13% +5.2%
EBITDA Margin 10.64% +68.7%
Operating Margin 2.94% +563.8%
Net Margin -3.9% -51.9%
ROE -5.82% -58.4%
ROIC 2.29% +590.8%
Debt/Equity 0.62 +2.9%
Interest Coverage 1.57 +517.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading near 52-week high

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-1.7%

5Y1%

3Y1.65%

TTM-1.43%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM150.3%

EPS CAGR

10Y-

5Y-

3Y-

TTM146.18%

ROCE

10Y Avg4.21%

5Y Avg0.85%

3Y Avg-1.54%

Latest2.52%

Peer Comparison

Medical Imaging Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
IRMDIRadimed Corporation	1.3B	102.57	68.38	11.71%	26.31%	21.54%	1.35%	0.00
BRKRBruker Corporation	7.52B	49.46	65.08	13.56%	-0.61%	-0.84%	1.81%	1.24
STESTERIS plc	26.33B	268.26	43.27	6.24%	12.07%	9.8%	2.95%	0.33
FONRFONAR Corporation	114.98M	18.64	15.15	1.43%	7.08%	4.62%	6.48%	0.24
HYPRHyperfine, Inc.	100.18M	1.22	-2.18	16.84%	-378.17%	-149.05%		0.01
PACBPacific Biosciences of California, Inc.	709.48M	2.35	-2.20	-23.19%	-325.8%	-13.95%		1.33
IRIXIRIDEX Corporation	23.21M	1.35	-2.50	-6.17%	-10.04%	-108.67%		2.21
MASS908 Devices Inc.	199.79M	5.52	-2.60	18.72%	-7.17%	-3.03%		0.06

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	24.24B	24.52B	17.78B	18.12B	17.15B	17.31B	17.16B	17.83B	18.17B	18.02B
Revenue Growth %	0.13%	0.01%	-0.27%	0.02%	-0.05%	0.01%	-0.01%	0.04%	0.02%	-0.01%
Cost of Goods Sold+	14.39B	13.9B	9.6B	9.57B	9.2B	9.4B	9.99B	10.63B	10.72B	10.25B
COGS % of Revenue	0.59%	0.57%	0.54%	0.53%	0.54%	0.54%	0.58%	0.6%	0.59%	0.57%
Gross Profit+	9.86B	10.61B	8.18B	8.55B	7.95B	7.91B	7.17B	7.19B	7.45B	7.77B
Gross Margin %	0.41%	0.43%	0.46%	0.47%	0.46%	0.46%	0.42%	0.4%	0.41%	0.43%
Gross Profit Growth %	0.2%	0.08%	-0.23%	0.05%	-0.07%	-0%	-0.09%	0%	0.04%	0.04%
Operating Expenses+	8.86B	8.73B	6.65B	6.83B	6.58B	6.65B	6.62B	8.72B	7.56B	7.24B
OpEx % of Revenue	0.37%	0.36%	0.37%	0.38%	0.38%	0.38%	0.39%	0.49%	0.42%	0.4%
Selling, General & Admin	7.02B	6.73B	4.97B	5.13B	4.56B	4.55B	4.86B	5.29B	5.13B	5.07B
SG&A % of Revenue	0.29%	0.27%	0.28%	0.28%	0.27%	0.26%	0.28%	0.3%	0.28%	0.28%
Research & Development	1.93B	2.02B	1.76B	1.76B	1.79B	1.91B	1.81B	2.09B	1.89B	1.75B
R&D % of Revenue	0.08%	0.08%	0.1%	0.1%	0.1%	0.11%	0.11%	0.12%	0.1%	0.1%
Other Operating Expenses	0	0	21M	9M	232M	183M	-48M	1.34B	541M	429M
Operating Income+	992M	1.88B	1.52B	1.72B	1.37B	1.26B	553M	-1.53B	-115M	529M
Operating Margin %	0.04%	0.08%	0.09%	0.09%	0.08%	0.07%	0.03%	-0.09%	-0.01%	0.03%
Operating Income Growth %	1.04%	0.9%	-0.19%	0.13%	-0.21%	-0.07%	-0.56%	-3.76%	0.92%	5.6%
EBITDA+	2.27B	3.15B	2.54B	2.81B	2.27B	2.33B	1.88B	73M	1.15B	1.92B
EBITDA Margin %	0.09%	0.13%	0.14%	0.15%	0.13%	0.13%	0.11%	0%	0.06%	0.11%
EBITDA Growth %	0.36%	0.39%	-0.19%	0.1%	-0.19%	0.03%	-0.2%	-0.96%	14.7%	0.67%
D&A (Non-Cash Add-back)	1.28B	1.27B	1.02B	1.09B	904M	1.07B	1.32B	1.6B	1.26B	1.39B
EBIT	782M	1.38B	1.62B	1.71B	1.72B	1.69B	673M	-1.49B	-220M	460M
Net Interest Income+	-223M	-421M	-81M	-219M	-96M	-178.98M	-146M	-219M	-260M	-257M
Interest Income	98M	76M	126M	51M	117M	14.82M	18M	25M	46M	79M
Interest Expense	467M	569M	263M	264M	233M	193.8M	164M	244M	306M	337M
Other Income/Expense	-329M	-75M	-140M	-216M	-119M	-53M	-44M	-202M	-412M	-406M
Pretax Income+	623M	1.39B	1.38B	1.5B	1.25B	1.21B	509M	-1.73B	-527M	123M
Pretax Margin %	0.03%	0.06%	0.08%	0.08%	0.07%	0.07%	0.03%	-0.1%	-0.03%	0.01%
Income Tax+	239M	327M	349M	193M	258M	212M	-103M	-113M	-73M	963M
Effective Tax Rate %	1.04%	1.04%	1.2%	0.73%	0.94%	0.98%	6.52%	0.93%	0.88%	-5.71%
Net Income+	645M	1.45B	1.66B	1.09B	1.17B	1.19B	3.32B	-1.61B	-466M	-702M
Net Margin %	0.03%	0.06%	0.09%	0.06%	0.07%	0.07%	0.19%	-0.09%	-0.03%	-0.04%
Net Income Growth %	0.55%	1.24%	0.14%	-0.34%	0.07%	0.02%	1.8%	-1.48%	0.71%	-0.51%
Net Income (Continuing)	160M	831M	1.03B	1.31B	989M	999M	612M	-1.62B	-454M	-840M
Discontinued Operations	479M	660M	843M	0	183M	196M	2.71B	13M	-10M	142M
Minority Interest	118M	907M	24M	29M	28M	31M	36M	34M	33M	37M
EPS (Diluted)+	0.66	1.46	1.64	1.09	1.20	1.23	0.64	-1.68	-0.49	-0.75
EPS Growth %	0.57%	1.21%	0.12%	-0.34%	0.1%	0.03%	-0.48%	-3.63%	0.71%	-0.53%
EPS (Basic)	0.66	1.48	1.67	1.11	1.21	1.25	0.67	-1.68	-0.49	-0.75
Diluted Shares Outstanding	984.45M	989.95M	1.01B	997.48M	972.79M	957.56M	950.28M	952.46M	948.79M	933.37M
Basic Shares Outstanding	976.41M	978.47M	989.96M	983.77M	962.2M	948.26M	907.46M	952.46M	948.79M	933.37M
Dividend Payout Ratio	0.46%	0.23%	0.23%	0.37%	0.43%	0%	0.17%	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	12.69B	14.07B	10.12B	9.57B	9.46B	11.23B	10.35B	10.26B	9.94B	10.02B
Cash & Short-Term Investments	1.78B	2.44B	1.94B	2.12B	1.43B	3.23B	2.31B	1.18B	1.87B	2.4B
Cash Only	1.77B	2.33B	1.94B	1.69B	1.43B	3.23B	2.3B	1.17B	1.87B	2.4B
Short-Term Investments	12M	101M	2M	436M	1M	0	2M	11M	3M	2M
Accounts Receivable	5.1B	5.63B	4.2B	4.18B	5.02B	4.16B	4.29B	4.65B	4.25B	3.67B
Days Sales Outstanding	76.72	83.81	86.3	84.24	106.84	87.64	91.23	95.27	85.4	74.37
Inventory	3.46B	3.39B	2.35B	2.67B	2.77B	2.99B	3.45B	4.05B	3.49B	3.2B
Days Inventory Outstanding	87.85	89.04	89.46	102.01	110.03	116.21	126.08	138.99	118.85	113.9
Other Current Assets	2.49B	2.66B	1.71B	776M	53M	682M	132M	200M	129M	511M
Total Non-Current Assets+	18.28B	18.23B	15.2B	16.45B	17.56B	16.49B	20.61B	20.43B	19.47B	18.95B
Property, Plant & Equipment	2.32B	2.15B	1.59B	1.71B	2.87B	2.68B	2.7B	2.64B	2.48B	2.45B
Fixed Asset Turnover	10.44x	11.38x	11.18x	10.58x	5.98x	6.46x	6.36x	6.76x	7.31x	7.35x
Goodwill	8.52B	8.9B	7.73B	8.5B	8.65B	8.01B	10.64B	10.24B	9.88B	10.38B
Intangible Assets	3.69B	3.55B	3.32B	3.59B	3.47B	3B	3.65B	3.53B	3.19B	2.98B
Long-Term Investments	670M	525M	729M	604M	481M	670M	1.06B	1.2B	1B	889M
Other Non-Current Assets	317M	306M	227M	211M	225M	303M	355M	381M	287M	332M
Total Assets+	30.98B	32.3B	25.32B	26.02B	27.02B	27.71B	30.96B	30.69B	29.41B	28.98B
Asset Turnover	0.78x	0.76x	0.70x	0.70x	0.63x	0.62x	0.55x	0.58x	0.62x	0.62x
Asset Growth %	0.09%	0.04%	-0.22%	0.03%	0.04%	0.03%	0.12%	-0.01%	-0.04%	-0.01%
Total Current Liabilities+	10.07B	10.47B	6.87B	7.94B	6.98B	7.74B	7.45B	7.93B	8.29B	8.14B
Accounts Payable	2.67B	2.85B	2.09B	2.3B	2.09B	2.12B	1.87B	1.97B	1.92B	1.83B
Days Payables Outstanding	67.81	74.76	79.46	87.85	82.89	82.27	68.41	67.56	65.26	65.18
Short-Term Debt	1.67B	1.58B	585M	1.3B	110M	962M	53M	95M	123M	224M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	3.07B	3.09B	1.96B	2.09B	937M	785M	1.39B	1.95B	1.93B	2.19B
Current Ratio	1.26x	1.34x	1.47x	1.21x	1.36x	1.45x	1.39x	1.29x	1.20x	1.23x
Quick Ratio	0.92x	1.02x	1.13x	0.87x	0.96x	1.06x	0.93x	0.78x	0.78x	0.84x
Cash Conversion Cycle	96.76	98.09	96.3	98.39	133.98	121.57	148.89	166.7	138.99	123.1
Total Non-Current Liabilities+	9.13B	8.32B	6.43B	5.96B	7.41B	8.08B	9.04B	9.47B	9.06B	8.79B
Long-Term Debt	3.95B	3.83B	3.85B	3.19B	3.77B	4.76B	4.77B	6.17B	6.09B	6.19B
Capital Lease Obligations	145M	194M	195M	236M	1.11B	948M	963M	852M	864M	854M
Deferred Tax Liabilities	164M	66M	33M	152M	143M	59M	83M	91M	71M	81M
Other Non-Current Liabilities	5.03B	4.3B	2.1B	2.53B	2.05B	1.91B	2.77B	1.85B	1.56B	1.23B
Total Liabilities	19.2B	18.8B	13.29B	13.9B	14.39B	15.81B	16.49B	17.41B	17.34B	16.93B
Total Debt+	5.76B	5.61B	4.72B	4.82B	5.26B	6.93B	6.05B	7.34B	7.29B	7.49B
Net Debt	3.99B	3.27B	2.78B	3.13B	3.83B	3.71B	3.74B	6.17B	5.42B	5.09B
Debt / Equity	0.49x	0.42x	0.39x	0.40x	0.42x	0.58x	0.42x	0.55x	0.60x	0.62x
Debt / EBITDA	2.53x	1.78x	1.86x	1.72x	2.32x	2.97x	3.22x	100.58x	6.36x	3.91x
Net Debt / EBITDA	1.76x	1.04x	1.09x	1.12x	1.69x	1.59x	2.00x	84.52x	4.73x	2.65x
Interest Coverage	2.12x	3.31x	5.77x	6.51x	5.86x	6.52x	3.37x	-6.27x	-0.38x	1.57x
Total Equity+	11.78B	13.51B	12.02B	12.12B	12.63B	11.9B	14.47B	13.28B	12.06B	12.04B
Equity Growth %	0.07%	0.15%	-0.11%	0.01%	0.04%	-0.06%	0.22%	-0.08%	-0.09%	-0%
Book Value per Share	11.97	13.65	11.94	12.15	12.98	12.43	15.23	13.95	12.71	12.90
Total Shareholders' Equity	11.66B	12.6B	12B	12.09B	12.6B	11.87B	14.44B	13.25B	12.03B	12.01B
Common Stock	186M	186M	188M	185M	179M	182M	177M	178M	183M	188M
Retained Earnings	8.04B	8.23B	8.6B	8.27B	8.3B	7.83B	9.34B	6.83B	5.4B	3.65B
Treasury Stock	-363M	-181M	-481M	-399M	-201M	-199M	-476M	-275M	-262M	-411M
Accumulated OCI	1.13B	1.28B	11.81B	11.9B	652M	-340M	748M	1.49B	879M	1.93B
Minority Interest	118M	907M	24M	29M	28M	31M	36M	34M	33M	37M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	1.17B	1.9B	1.87B	1.78B	2.27B	2.64B	1.93B	-181.82M	2.31B	1.7B
Operating CF Margin %	0.05%	0.08%	0.11%	0.1%	0.13%	0.15%	0.11%	-0.01%	0.13%	0.09%
Operating CF Growth %	-0.1%	0.63%	-0.02%	-0.05%	0.28%	0.16%	-0.27%	-1.09%	13.7%	-0.27%
Net Income	414M	1.07B	1.03B	1.31B	1.33B	1.19B	718.64M	-1.7B	-492.99M	-912.95M
Depreciation & Amortization	1.28B	1.27B	1.02B	1.09B	1.09B	1.46B	1.24B	1.26B	1.39B	1.26B
Stock-Based Compensation	82M	95M	122M	102M	0	112M	0	0	0	0
Deferred Taxes	239M	327M	349M	193M	0	284M	0	0	0	0
Other Non-Cash Items	382M	1.25B	1.46B	962M	609.99M	131M	143.02M	1.5B	-98.38M	1.35B
Working Capital Changes	-346M	-512M	-509M	-500M	-755.49M	-536M	-179.66M	-1.24B	1.51B	7.57M
Change in Receivables	-554M	357M	64M	-97M	0	92M	0	-359.43M	322.17M	-1.08M
Change in Inventory	22M	44M	-144M	-394M	-195.87M	-578M	-686.73M	-601.16M	277.85M	248.79M
Change in Payables	464M	-154M	0	0	-413M	0	258.85M	54.65M	387.04M	-630.63M
Cash from Investing+	-1.94B	-1.17B	-3.2B	-1.49B	-702.89M	-1.27B	-317.95M	-1.58B	-553.53M	-633.87M
Capital Expenditures	-957M	-869M	-859M	-843M	-1.13B	-895M	-901.85M	-847.09M	-695.16M	-731.22M
CapEx % of Revenue	0.04%	0.04%	0.05%	0.05%	0.07%	0.05%	0.05%	0.05%	0.04%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	516M	-1.11B	-463M	-549M	-27.98M	20M	4.02B	-12.61M	134.06M	27.04M
Cash from Financing+	508M	-420M	55M	-1.19B	-1.86B	483M	-2.77B	525.49M	-916.79M	-536.52M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-298M	-330M	-384M	-401M	-507.02M	-1M	-569.71M	-433M	-2.16M	-1.08M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	81M	2.98B	1.3B	125M	-2.24M	60M	-2.36M	-6.31M	-3.24M	-2.16M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	210M	1.03B	1.01B	937M	1.69B	2.15B	1.46B	-648.45M	1.94B	1.35B
FCF Margin %	0.01%	0.04%	0.06%	0.05%	0.1%	0.12%	0.08%	-0.04%	0.11%	0.08%
FCF Growth %	-0.54%	3.93%	-0.02%	-0.07%	0.81%	0.27%	-0.32%	-1.44%	3.99%	-0.3%
FCF per Share	0.21	1.05	1.00	0.94	1.74	2.25	1.53	-0.68	2.04	1.45
FCF Conversion (FCF/Net Income)	1.81x	1.31x	1.13x	1.63x	1.95x	2.22x	0.58x	0.11x	-4.96x	-2.42x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	5.67%	11.45%	12.98%	9.03%	9.43%	9.68%	25.17%	-11.59%	-3.68%	-5.82%
Return on Invested Capital (ROIC)	5.14%	8.67%	7.21%	8.58%	6.46%	5.91%	2.45%	-6.09%	-0.47%	2.29%
Gross Margin	40.65%	43.29%	46.01%	47.2%	46.35%	45.7%	41.78%	40.35%	40.99%	43.13%
Net Margin	2.66%	5.91%	9.32%	6.02%	6.81%	6.86%	19.35%	-9.02%	-2.56%	-3.9%
Debt / Equity	0.49x	0.42x	0.39x	0.40x	0.42x	0.58x	0.42x	0.55x	0.60x	0.62x
Interest Coverage	2.12x	3.31x	5.77x	6.51x	5.86x	6.52x	3.37x	-6.27x	-0.38x	1.57x
FCF Conversion	1.81x	1.31x	1.13x	1.63x	1.95x	2.22x	0.58x	0.11x	-4.96x	-2.42x
Revenue Growth	13.34%	1.12%	-27.48%	1.92%	-5.38%	0.97%	-0.91%	3.91%	1.92%	-0.81%

Revenue by Geography

	2017	2018	2019	2020	2021	2022	2024
UNITED STATES	-	-	6.67B	-	-	-	7.23B
UNITED STATES Growth	-	-	-	-	-	-	-
Other countries	5.93B	6.09B	6.34B	6.43B	5.04B	5.08B	5.6B
Other countries Growth	-	2.56%	4.12%	1.48%	-21.64%	0.89%	10.05%
NETHERLANDS	-	-	522M	-	-	-	2.51B
NETHERLANDS Growth	-	-	-	-	-	-	-
CHINA	-	-	2.71B	-	-	-	1.15B
CHINA Growth	-	-	-	-	-	-	-
JAPAN	-	-	1.19B	-	-	-	886M
JAPAN Growth	-	-	-	-	-	-	-
GERMANY	-	-	1.09B	-	-	-	653M
GERMANY Growth	-	-	-	-	-	-	-
United States of America	-	6.05B	-	6.64B	6.42B	7.25B	-
United States of America Growth	-	-	-	-	-3.25%	12.87%	-
China	2.32B	2.38B	-	2.43B	2.33B	2.19B	-
China Growth	-	2.50%	-	-	-3.99%	-6.08%	-
Japan	1.06B	1.04B	-	1.31B	1.07B	1.08B	-
Japan Growth	-	-1.32%	-	-	-18.34%	0.37%	-
Germany	1.01B	1.03B	-	1.11B	839M	821M	-
Germany Growth	-	2.08%	-	-	-24.62%	-2.15%	-
Netherlands	414M	510M	-	555M	570M	540M	-
Netherlands Growth	-	23.19%	-	-	2.70%	-5.26%	-
United Kingdom of Great Britain and Northern Ireland	-	-	-	-	481M	463M	-
United Kingdom of Great Britain and Northern Ireland Growth	-	-	-	-	-	-3.74%	-
France	530M	519M	-	545M	397M	400M	-
France Growth	-	-2.08%	-	-	-27.16%	0.76%	-
Korea (Republic of)	-	498M	-	509M	-	-	-
Korea (Republic of) Growth	-	-	-	-	-	-	-
FRANCE	-	-	505M	-	-	-	-
FRANCE Growth	-	-	-	-	-	-	-
KOREA, REPUBLIC OF	-	-	470M	-	-	-	-
KOREA, REPUBLIC OF Growth	-	-	-	-	-	-	-
United States	6.08B	-	-	-	-	-	-
United States Growth	-	-	-	-	-	-	-
India	425M	-	-	-	-	-	-
India Growth	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Koninklijke Philips N.V. (PHG) reported $17.78B in revenue for fiscal year 2024. This represents a 21% decrease from $22.58B in 2011.

Koninklijke Philips N.V. (PHG) saw revenue decline by 0.8% over the past year.

Yes, Koninklijke Philips N.V. (PHG) is profitable, generating $165.0M in net income for fiscal year 2024 (-3.9% net margin).

Dividend & Returns

Koninklijke Philips N.V. (PHG) does not currently pay a meaningful dividend. The company may be reinvesting profits for growth.

Koninklijke Philips N.V. (PHG) has a return on equity (ROE) of -5.8%. Negative ROE indicates the company is unprofitable.

Koninklijke Philips N.V. (PHG) had negative free cash flow of $552.8M in fiscal year 2024, likely due to heavy capital investments.